Converting Viral Villains to Cancer Cures: Oncolytic Virotherapy Creeps Closer to the Clinic

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.11, 2005-01, pp. : 8-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic Virotherapy for Breast Cancer Treatment

Current Gene Therapy, Vol. 18, Iss. 4, 2018-08 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6513-6521

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase-Specific Oncolytic Virotherapy for Human Cancer with the hTERT Promoter

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1809-1816

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets

By Halldén Gunnel Portella Giuseppe

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 945-958

Informa Healthcare

Access to resources Recommend Favorite